Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
4.580
-0.210 (-4.38%)
At close: Oct 23, 2026, 4:00 PM EDT
4.590
+0.010 (0.22%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.63 billion as of October 23, 2026. It is the 7,525th most valuable company in the world and the 1,911th biggest in the United States. Its market cap has decreased by 36.55% in one year.
Market Cap
1.63B
Enterprise Value
2.94B
1-Year Change
-36.55%
Global Rank
Country Rank
#1,911 United States
Category
ChartMarket Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.63B, an increase of 436.50%. That is a compound annual growth rate of 32.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 1.63B | 1.80% |
| Dec 31, 2025 | 1.61B | -59.76% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Supernus Pharmaceuticals | 2.37B |
| Prestige Consumer Healthcare | 2.26B |
| Perrigo Company | 2.21B |
| Trulieve Cannabis | 2.01B |
| BioCryst Pharmaceuticals | 1.95B |
| Xeris Biopharma Holdings | 1.86B |
| Phibro Animal Health | 1.58B |
| ANI Pharmaceuticals | 1.56B |